Related Experiment Video
Updated: Feb 23, 2026
Improved Enzyme Protection Assay to Study Staphylococcus aureus Internalization and Intracellular Efficacy of Antimicrobial Compounds
Published on: September 8, 2021
Optimized efflux assay for the NorA multidrug efflux pump in Staphylococcus aureus
Saskia Zimmermann1, Lorena Tuchscherr1, Jürgen Rödel2
1Institute of Medical Microbiology, Jena University Hospital, Am Klinikum 1, D-07747 Jena, Germany; Jena University Hospital, Integrated Research and Treatment Center, Center for Sepsis Control and Care (CSCC), Am Klinikum 1, D-07747 Jena, Germany.
This study optimized a real-time fluorescent assay for bacterial efflux pumps, specifically the NorA pump in Staphylococcus aureus. The new method uses DiOC3 and is fast and reproducible for efflux pump research.
Area of Science:
- Microbiology
- Biochemistry
Background:
- Bacterial efflux pumps are crucial for multidrug resistance.
- Real-time fluorescent assays are standard for measuring efflux pump activity.
- Optimizing these assays is vital for accurate drug resistance studies.
Purpose of the Study:
- To develop an optimized protocol for assessing the NorA efflux pump in Staphylococcus aureus.
- To evaluate DiOC3 as a fluorescent substrate for efflux assays.
- To test glucose and sodium formate as energy sources for the efflux pump.
Main Methods:
- Real-time fluorescent efflux assay.
- Utilized DiOC3 as the fluorescent substrate.
- Investigated glucose and sodium formate as energy substrates for the NorA efflux pump in S. aureus.
Main Results:
- An optimized protocol for the NorA efflux pump in S. aureus was established.
- DiOC3 proved effective for real-time efflux measurements.
- Glucose and sodium formate were confirmed as viable energy carriers.
Conclusions:
- The developed DiOC3-based assay provides a fast and reproducible method for studying bacterial efflux pumps.
- This optimized protocol enhances the study of efflux pump mechanisms and drug resistance in S. aureus.
More Related Videos
10:00Targeting Biofilm Associated Staphylococcus aureus Using Resazurin Based Drug-susceptibility Assay
Published on: May 5, 2016
05:06Author Spotlight: Advancing Antibiotic Resistance Research Using an Efflux-Deficient Bacterial Strain and a Single-Copy Gene Expression System
Published on: January 5, 2024